Vectura

July 17, 2019

Vectura moves to appease long-term shareholders

January 31, 2019

Mylan makes for a piece of the shrinking Advair pie

November 26, 2018

Vectura’s VR475 runs out of puff

September 05, 2018

Pojasek departure takes Immunocore’s C-suite bloodletting to six

August 20, 2018

Amid Immunocore’s C-suite bloodletting Glaxo provides solace

Immunocore has recently been beset with multiple senior executive departures, but has managed to press on into phase I with a Glaxo-partnered asset.

March 26, 2018

Verona’s transformation clears its first hurdle

August 18, 2017

Snippet roundup: Transparency for Straumann but a black box for Pfizer

May 12, 2017

Snippet roundup: Sighs of relief for Astra and Glaxo

March 29, 2017

Triggering Article 50 leaves outlook for healthcare no clearer